REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jiangsu Gdk Biological Technology Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jiangsu Gdk Biological Technology Co., Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Jiangsu Gdk Biotechnology Co., Ltd. focuses on the R & D, production and sales of human vaccines. The company was founded in 2008 and headquartered in Taizhou City, China.

Headquarters
No. 12, Yujin Road, Taizhou City, Jiangsu Province
Taizhou; Jiangsu; Postal Code: 225300

Contact Details: Purchase the Jiangsu Gdk Biological Technology Co., Ltd report to view the information.

Website: http://www.gdkbio.com

Basic Information
Total Employees:
Purchase the Jiangsu Gdk Biological Technology Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Jiangsu Gdk Biological Technology Co., Ltd report to view the information.
Registered Capital:
Purchase the Jiangsu Gdk Biological Technology Co., Ltd report to view the information.
Financial Auditors:
Purchase the Jiangsu Gdk Biological Technology Co., Ltd report to view the information.
Incorporation Date:
December 29, 2008
Key Executives
Purchase this report to view the information.
SECRETARY
Ownership Details
Purchase this report to view the information.
30.74%
Purchase this report to view the information.
30.74%
Purchase this report to view the information.
4.61%
Purchase this report to view the information.
3.84%
Purchase this report to view the information.
2.37%
Subsidiaries
Taizhou Jindike Poultry Industry Co., Ltd.
Company Performance
Financial values in the chart are available after Jiangsu Gdk Biological Technology Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-67.81%▼
Total operating revenue
-61.99%▼
Operating profit (EBIT)
-278.35%▼
Net Profit (Loss) for the Period
-382.63%▼
Total assets
-9.37%▼
Total equity
-7.92%▼
Operating Profit Margin (ROS)
-148.7%▼
Net Profit Margin
-128.27%▼
Return on Equity (ROE)
-3.29%▼
Debt to Equity Ratio
-0.44%▼
Quick Ratio
-0.23%▼
Cash Ratio
-1.4%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Frontier Biotechnologies Inc. (前沿生物药业(南京)股份有限公司)
 
Shanghai Micurx Pharmaceutical Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd. (迈威(上海)生物科技股份有限公司)
 
Hangzhou Tianmushan Pharmaceutical Enterprise Co.,Ltd
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司)
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo